AbbVie to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

On June 2, 2021 AbbVie (NYSE: ABBV) reported that it will participate in the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021 (Press release, AbbVie, JUN 2, 2021, View Source [SID1234583366]). Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present virtually at 8:40 a.m. Central time.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.